Walts Alan Edmund 4
4 · Eloxx Pharmaceuticals, Inc. · Filed Jan 28, 2025
Insider Transaction Report
Form 4
Walts Alan Edmund
Director
Transactions
- Exercise/Conversion
Common Stock
2025-01-24+3,750→ 16,692 total - Exercise/Conversion
Restricted Stock Units
2025-01-24−3,750→ 3,750 total→ Common Stock (3,750 underlying)
Footnotes (2)
- [F1]Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
- [F2]The RSUs vest as to 50% on the first anniversary of January 24, 2024 and, as to the remaining amount, in two equal annual installments thereafter, subject to the Reporting Person's continuous service to the Issuer through each applicable vesting date.